Phase I study of liposomal irinotecan in patients with metastatic breast cancer: findings from the expansion phase
Jasgit C. Sachdev(HonorHealth), Carey K. Anders(Duke University), Tiffany Wang(Yale University), X. Cynthia(Washington University in St. Louis), Arunthathi Thiagalingam(Essen BioScience (United States)), Donald W. Northfelt(Mayo Clinic in Arizona), Hyo S. Han(Moffitt Cancer Center), Fiona Maxwell(Ipsen (United Kingdom)), Pamela N. Münster(University of California, San Francisco), Yan Moore(Sanofi (United States)), Bin Zhang(King Abdullah University of Science and Technology), Bruce Belanger(Ipsen (United States))
Cited by 45
Related Papers
Hepatobiliary Cancers
|Journal of the National Comprehensive Cancer Network|2009|2.3k
Tucatinib, Trastuzumab, and Capecitabine for HER2-Positive Metastatic Breast Cancer
|New England Journal of Medicine|2019|1.3k
Brain metastases
|Nature Reviews Disease Primers|2019|1.1k
Young Age at Diagnosis Correlates With Worse Prognosis and Defines a Subset of Breast Cancers With Shared Patterns of Gene Expression
|Journal of Clinical Oncology|2008|917
Breast Cancer Before Age 40 Years
|Seminars in Oncology|2009|795